Can-Fite BioPharma Ltd.
PublicCan-Fite BioPharma Ltd. is now publicly traded
The data on this page reflects Can-Fite BioPharma Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed Round
Sep 2, 2026
Total Funding Raised
$56.77M
Company Overview
Can-Fite BioPharma Ltd. operates in Healthcare and is based in Israel. It has raised $56.77M.
Can-Fite BioPharma Ltd. is a clinical-stage biopharmaceutical company that develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver, and inflammatory diseases.
Sector
Healthcare
AI Layer
Non-AI
Can-Fite BioPharma Ltd. Comparables
Compare Can-Fite BioPharma Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spero Biopharma | 59% |
For institutional investors. Book with your work email.
Can-Fite BioPharma Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 2, 2026 | ||||
| Private Placement | Jun 10, 2020 | ||||
| Private Placement | Jan 9, 2020 | ||||
| Private Placement | May 20, 2019 | ||||
| Private Placement | Mar 13, 2018 | ||||
Private Placement | Jan 24, 2017 |
For institutional investors. Book with your work email.
Can-Fite BioPharma Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.